EE199 Cost-Effectiveness of Pembrolizumab for the First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Colombia
Abstract
Authors
J. Urrego-Reyes C. Lopez C. Marrugo A. V. Wurcel A. Khandelwal A. Patel C. Black